THERAPEUTIC AGENT FOR BILE DUCT CANCER

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20180015079A1
SERIAL NO

15547139

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides a therapeutic agent for bile duct cancer comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EISAI R&D MANAGEMENT CO LTDTOKYO JAPAN
NATIONAL CANCER CENTER1-1 TSUKIJI 5-CHOME CHUO-KU TOKYO 104-0045

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ARAI, Yasuhito Tokyo, JP 2 1
MIYANO, Saori Tsukuba, JP 8 2
NAKAMURA, Tomio Tokyo, JP 16 83
NOMOTO, Kenichi Andover, US 22 111
SHIBATA, Tatsuhiro Tokyo, JP 6 47
TSURUOKA, Akihiko Tokyo, JP 29 753

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation